Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03963427
Other study ID # Bröst-07:2-4
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date March 8, 2008
Est. completion date December 1, 2024

Study information

Verified date August 2023
Source Vastra Gotaland Region
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A randomized clinical trial with two arms: irradiated women and non-irradiated women. Irradiated women are randomized to reconstruction with a latissimus Dorsi flap and an implant or a deep inferior epigastria perforator flap. Non-irradiated women are randomized to reconstruction with a thoracodorsal flap with an implant or with an expander and later a permanent implant in two stages.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 220
Est. completion date December 1, 2024
Est. primary completion date April 1, 2020
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 60 Years
Eligibility Irradiated patients: Inclusion Criteria: - Age 18-60 - DIEP is technically possible - Unilateral mastectomy - BMI<30 Exclusion Criteria: - Scars on abdomen or back - Bilateral mastectomy - Previous liposuction abdomen - 61 years of age or older Non-irradiated patients Inclusion Criteria: ->18 years of age - Unilateral mastectomy - BMI<30 Exclusion Criteria: - Bilateral mastectomy - extensive scars on thorax

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Breast reconstruction
Irradiated women are randomized to reconstruction with a latissimus Dorsi flap and an implant or a deep inferior epigastria perforator flap. Non-irradiated women are randomized to reconstruction with a thoracodorsal flap with an implant or with an expander and later a permanent implant in two stages.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Vastra Gotaland Region

References & Publications (1)

Brorson F, Thorarinsson A, Kolby L, Elander A, Hansson E. Early complications in delayed breast reconstruction: A prospective, randomized study comparing different reconstructive methods in radiated and non-radiated patients. Eur J Surg Oncol. 2020 Dec;46 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Aesthetic outcome Photo evaluations 1 year post-operatively
Secondary Breast related quality of life and satisfaction Breast-q. Measures breast related quality of life on a scale 1-100. A higher score indicates a higher quality of life. Pre-operatively and 3 years post-operatively
Secondary General quality of life measurement used for health economics EuroQol-5 domensions-3 levels is a generic instrument developed for health economic and clinical evaluation of healthcare. A total score between 0 and 1 is calculated. Zero equals death and 1 perfect health. Pre-operatively and 3 years post-operatively
Secondary Depression Beck Depression Inventory (BDI 21) for mood assessment. Scale range is 0-63 and higher scores indicate worse outcome. Pre-operatively and 3 years post-operatively
Secondary General quality of life Short form health survey (SF-36). The scale ranges from 0 to 100 and a higher score indicates a better quality of life. Pre-operatively and 3 years post-operatively
Secondary Early complication frequency Complications described according to Clavien-Dindo 2 weeks post-operatively
Secondary Long-term complications Re-operations and corrections Five years post-operatively
Secondary Health economics Costs of different procedures Five years post-operatively
Secondary Implant survival Analysis of number of implants removed over time 19 years
See also
  Status Clinical Trial Phase
Completed NCT03080623 - Ultrasound-based Diagnostic Model for Differentiating Malignant Breast Lesion From Benign Lesion
Completed NCT05527769 - Pain and Functional Recovery After Mastectomy and IBR by Implant: Prepectoral Versus Subpectoral Technique
Completed NCT06376578 - Exercise Interventions for Improving Health in Breast Cancer Survivors N/A
Completed NCT03004534 - A Study to Evaluate Changes in Human Breast Cancer Tissue Following Short-Term Use of Darolutamide Early Phase 1
Recruiting NCT05020574 - Microbiome and Association With Implant Infections Phase 2
Active, not recruiting NCT06277141 - The Vitality Mammography Messaging Study N/A
Completed NCT03270111 - High Physical Activity During a Weight Loss Intervention for Breast Cancer Survivors and High Risk Women N/A
Completed NCT03555227 - USG PECS vs LIA for Breast Cancer Surgery N/A
Active, not recruiting NCT03917082 - Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer Phase 2
Recruiting NCT05561842 - Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)
Completed NCT04554056 - Trial to Compare the Efficacy and Safety Of MW05 and PEG-rhG-CSF Phase 2/Phase 3
Not yet recruiting NCT06351332 - A Phase I/II Single-arm Trial of Azenosertib (ZN-c3) Combined With Carboplatin and Pembrolizumab in Patients With Metastatic Triple-negative Breast Cancer (ZAP-IT) Phase 1/Phase 2
Active, not recruiting NCT03127995 - Hypofractionated vs Standard Radiotherapy in Breast Cancer With an Indication for Regional Lymph Node Irradiation About Lymphedema Occurrence N/A
Active, not recruiting NCT02237469 - Prone Breast Radiotherapy Treatment Planning Observational Study
Completed NCT01204125 - Two Regimens of SAR240550/Weekly Paclitaxel and Paclitaxel Alone as Neoadjuvant Therapy in Triple Negative Breast Cancer Patients Phase 2
Recruiting NCT04565054 - Adjuvant Therapy With Abemaciclib + SOC ET vs. SOC ET in Clinical or Genomic High Risk, HR+/HER2- EBC Phase 3
Not yet recruiting NCT06412133 - Conversations in Light and Shadow: Assessing Phototherapy's Impact on Breast Cancer Patients N/A
Recruiting NCT03956641 - Evolution of the Physical Condition in Treated Cancer Patients N/A
Recruiting NCT06087120 - Investigate the Prognostic and Predictive Value of ctDNA During Neoadjuvant Chemotherapy for Breast Cancer.
Recruiting NCT06058936 - Exercises Using Virtual Reality on Cancer Patients N/A

External Links